BACKGROUND: Racial disparities in breast cancer outcomes are attributed to differences in
baseline tumour characteristics and biology, stage, age, ethnic background and …

Purpose To explore racial differences in the use and outcome of neoadjuvant chemotherapy
for breast cancer. Methods The National Cancer Data Base was queried to identify women …

The effect of race on breast cancer outcome is confounded by tumor and treatment
heterogeneity. We examined a cohort of women with stage II–III breast cancer treated …

Background Black patients with breast cancer may be at greater risk for chemotherapy-
related hematologic toxicity than white patients because of lower baseline blood cell counts …

Purpose We conducted a systematic review and meta-analysis to measure the extent to
which race is associated with delayed initiation or receipt of inadequate chemotherapy …

Importance Among patients with breast cancer, inconsistent findings have been published
on racial disparities in achieving pathologic complete response (pCR) after neoadjuvant …

Purpose There are a paucity of data and a pressing need to evaluate response to
neoadjuvant chemotherapy (NACT) and determine long-term outcomes in young Black …

Objective. To examine racial disparities associated with breast cancer treatment and survival
in elderly patients with early stage operable breast cancer. Methods. We studied 23,110 …

Abstract BACKGROUND. African‐American (AA) race has been associated with a worse
outcome in breast cancer. It is unclear whether this is due to biological factors …

Purpose Black women with breast cancer are known to have poorer survival than white
women. Suboptimal treatment may compromise the survival benefits of adjuvant …